Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
October 15, 2024
02:00 PM - 03:00 PM EDT
Pulmonary Hypertension: Diagnosis, Management, and Updates
Pulmonary Hypertension: Diagnosis, Management, and Updates
November 16, 2024
07:00 PM - 08:30 PM CST
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
Strategies to Implement Risk Stratification in the PH Clinic
Strategies to Implement Risk Stratification in the PH Clinic
Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH
Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH
Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification
Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification
Macitentan Update: Impact on Management of Pulmonary Hypertension
Macitentan Update: Impact on Management of Pulmonary Hypertension
Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
